Hematology & Medical Oncology Research

We are committed to finding new and better ways to predict, prevent, diagnose and treat nonmalignant hematologic conditions, blood cancers and solid tumors and to advancing the future of hematology and oncology. Our world-renowned physician-scientists and scientists collaborate closely across disciplines and with investigators worldwide, leading research and spearheading numerous studies and clinical trials, translating novel scientific discoveries into new diagnostics and treatments, and helping improve clinical outcomes. Home to the first Sickle Cell Center and Research Laboratory and one of the first National Cancer Institute-designated cancer centers in the U.S., we continue to lead the way with transformative hematology and cancer research.

We are spearheading all phases and types of clinical trials, for individuals with nonmalignant hematologic conditions, blood cancers and solid tumors, some of which are sponsored by the National Institutes of Health. By enrolling in a clinical trial, you can help our scientists develop new treatments, diagnostic tools and other strategies to prevent, diagnose and treat these conditions. Through our clinical trials, you may also be able to access emerging technologies and innovative treatments that may otherwise not be available to the general public.